Home/Filings/4/0001104659-20-044168
4//SEC Filing

Cavan John T 4

Accession 0001104659-20-044168

CIK 0001583771other

Filed

Apr 6, 8:00 PM ET

Accepted

Apr 7, 4:13 PM ET

Size

5.3 KB

Accession

0001104659-20-044168

Insider Transaction Report

Form 4
Period: 2020-04-03
Cavan John T
Chief Financial Officer
Transactions
  • Award

    Stock Options

    2020-04-03+215,000221,059 total
    Exercise: $1.63Exp: 2030-04-03Common Stock (215,000 underlying)
Footnotes (1)
  • [F1]71,667 of the stock options vest on 4/3/2021 and the remainder vests monthly in equal amounts over 24 months.

Documents

1 file

Issuer

Hepion Pharmaceuticals, Inc.

CIK 0001583771

Entity typeother

Related Parties

1
  • filerCIK 0001503738

Filing Metadata

Form type
4
Filed
Apr 6, 8:00 PM ET
Accepted
Apr 7, 4:13 PM ET
Size
5.3 KB